Edward C Albini Sutro Biopharma, Inc. (STRO) insider trading activity

Edward C Albini is CFO AND SECRETARY of SUTRO BIOPHARMA, INC.. Currently has a direct ownership of 132,081 shares of STRO, which is worth approximately $97,739. The most recent transaction as insider was on Mar 05, 2025, when has been sold 3,594 shares (Common Stock) at a price of $1.36 per share, resulting in proceeds of $4,887. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

23.74% 3M change

23.74% 12M change

Total Value Held $97,739

EDWARD C ALBINI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Payment of exercise price or tax liability	$4,887 $1.36 p/Share	3,594 Reduced 2.65%	132,081 Common Stock
Mar 05 2025	BUY Exercise of conversion of derivative security	-	8,750 Added 6.06%	135,675 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$5,322 $1.42 p/Share	3,748 Reduced 2.87%	126,925 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	9,125 Added 6.53%	130,673 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$16,408 $1.59 p/Share	10,320 Reduced 7.83%	121,548 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	25,125 Added 16.0%	131,868 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$14,074 $4.54 p/Share	3,100 Reduced 2.82%	106,743 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	-	8,750 Added 7.38%	109,843 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$16,630 $4.79 p/Share	3,472 Reduced 3.32%	101,093 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	-	9,125 Added 8.03%	104,565 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$15,973 $4.95 p/Share	3,227 Reduced 3.27%	95,440 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	7,875 Added 7.39%	98,667 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$10,733 $4.99 p/Share	2,151 Reduced 2.31%	90,792 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	-	5,250 Added 5.35%	92,943 Common Stock
Feb 13 2023	BUY Exercise of conversion of derivative security	$265,505 $5.81 p/Share	45,698 Added 37.43%	76,406 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$16,050 $7.5 p/Share	2,140 Reduced 6.51%	30,708 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	-	5,250 Added 13.78%	32,848 Common Stock
Mar 05 2022	SELL Payment of exercise price or tax liability	$25,695 $8.17 p/Share	3,145 Reduced 10.23%	27,598 Common Stock
Mar 05 2022	BUY Exercise of conversion of derivative security	-	8,750 Added 22.16%	30,743 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$22,349 $10.39 p/Share	2,151 Reduced 8.91%	21,993 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	5,250 Added 17.86%	24,144 Common Stock
Sep 24 2021	SELL Payment of exercise price or tax liability	$47,690 $19.23 p/Share	2,480 Reduced 11.6%	18,894 Common Stock
Sep 24 2021	BUY Exercise of conversion of derivative security	-	7,174 Added 25.13%	21,374 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$47,091 $22.15 p/Share	2,126 Reduced 13.02%	14,200 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	-	5,250 Added 24.33%	16,326 Common Stock

ECA

Edward C Albini

CFO AND SECRETARY

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STRO shares.

Notify only if

Value

Insider Trading

Get notified when an Sutro Biopharma, Inc. insider buys or sells STRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUTRO BIOPHARMA, INC.

Track Activities on STRO

Account